Austin, Texas
CNS clinical trials in Austin, TX
69 CNS studies are recruiting participants at sites in Austin as of November 16, 2026, according to ClinicalTrials.gov. CNS Clinical Research can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Austin at a glance
- 69 studies are recruiting at a site in Austin.
- By phase: Early Phase 1 (1), Phase 1 (3), Phase 1/2 (1), Phase 2 (16), Phase 3 (29), Phase 4 (3), No phase (13), Observational (3). Studies of devices and behavioral approaches have no phase.
- By sponsor: industry (55), university, hospital or other (14).
- By research area: Depression (21), Migraine (14), Schizophrenia (10), ADHD (7), Multiple Sclerosis (7), Bipolar Disorder (5), Epilepsy (3), Parkinson's Disease (2).
- Most recent update to one of these records: November 16, 2026.
Depression studies recruiting in Austin
Basic details from each study's public record (the 30 most recently updated of 69). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Study site
- Dell Medical School, University of Texas at Austin
- Registry record
- NCT07002034 · updated
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Phase 3
- Ages 18 to 74
- All sexes
- Sponsor
- Definium Therapeutics US, Inc.
- Study site
- Austin Clinical Trial Partners
- Registry record
- NCT07592689 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Study site
- UT Health Austin, Mulva Clinic for the Neurosciences
- Registry record
- NCT03887715 · updated
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
- Phase 3
- Ages 10 to 17
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- The University of Texas at Austin
- Registry record
- NCT06372964 · updated
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Phase 2
- Ages 18 and older
- All sexes
- Sponsor
- Tonix Pharmaceuticals, Inc.
- Registry record
- NCT07621237 · updated
Study of ALTO-300 in MDD
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT05922878 · updated
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- No phase
- Ages 22 to 70
- All sexes
- Sponsor
- Abbott Medical Devices
- Study site
- University of Texas Austin Dell Medical School
- Registry record
- NCT06423430 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Austin, TX on ClinicalTrials.gov.
Schizophrenia studies recruiting in Austin
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Phase 2
- Ages 55 to 90
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT06887192 · updated
A Study of the Feasibility, Safety and Tolerability of Aticaprant as Adjunctive Treatment in Participants With Schizophrenia
- Phase 1
- Ages 18 to 60
- All sexes
- Sponsor
- Janssen Research & Development, LLC
- Study site
- Community Clinical Research, Inc.
- Registry record
- NCT07615426 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Senior Adults Specialty Research
- Registry record
- NCT06585787 · updated
A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- MapLight Therapeutics
- Registry record
- NCT07459647 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Austin, TX on ClinicalTrials.gov.
Bipolar disorder studies recruiting in Austin
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Community Clinical Research
- Registry record
- NCT07140913 · updated
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Community Clinical Research
- Registry record
- NCT06929273 · updated
A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Bristol-Myers Squibb
- Study site
- Community Clinical Research
- Registry record
- NCT06951698 · updated
Source: ClinicalTrials.gov. Data processed . See every bipolar disorder study recruiting in Austin, TX on ClinicalTrials.gov.
ADHD studies recruiting in Austin
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
- Phase 3
- Ages 6 to 11
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717879 · updated
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
- Phase 3
- Ages 12 to 17
- All sexes
- Sponsor
- Axsome Therapeutics, Inc.
- Registry record
- NCT07717892 · updated
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Study site
- Donald J. Garcia, Jr, MD, PA
- Registry record
- NCT07759154 · updated
A Study to Evaluate Safety and Efficacy of ALKS 7290 Compared With Placebo in Adult Participants With Attention Deficit Hyperactivity Disorder (ALKS 7290-201)
- Phase 2
- Ages 18 to 65
- All sexes
- Sponsor
- Alkermes, Inc.
- Study site
- Alkermes Investigational Site
- Registry record
- NCT07755410 · updated
Source: ClinicalTrials.gov. Data processed . See every ADHD study recruiting in Austin, TX on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Austin
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Austin, TX on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Austin
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial Site
- Registry record
- NCT06433752 · updated
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Phase 3
- Ages 40 to 70
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Austin Regional Clinic
- Registry record
- NCT06846281 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Austin, TX on ClinicalTrials.gov.
Epilepsy studies recruiting in Austin
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Child Neurology & Consultants of Austin
- Registry record
- NCT05667142 · updated
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study site
- Austin Epilepsy Care Center
- Registry record
- NCT05716100 · updated
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
- Phase 3
- Ages 2 and older
- All sexes
- Sponsor
- Epygenix
- Study site
- Child Neurology Consultants of Austin
- Registry record
- NCT04462770 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Austin, TX on ClinicalTrials.gov.
Migraine studies recruiting in Austin
Study of EVO756 in Adults With Migraine
- Phase 2
- Ages 18 to 64
- All sexes
- Sponsor
- Evommune, Inc.
- Study site
- FutureSearch Trials of Neurology
- Registry record
- NCT07616128 · updated
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- Central Texas Clinical Research
- Registry record
- NCT07816367 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- FutureSearch Trials of Neurology · Tekton Research
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study sites
- FutureSearch Trials of Neurology · Tekton Research
- Registry record
- NCT07674654 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- Dell Children's Medical Center
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study sites
- Child Neurology Consultants of Austin - Central Austin · Dell Children's Medical Center
- Registry record
- NCT04743141 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Austin, TX on ClinicalTrials.gov.
Ask about studies near Austin
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Texas
All Texas locations
263 studies recruiting across 56 cities.
Houston
127 studies recruiting.
Dallas
66 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections